Elidel

Active Ingredient(s): Pimecrolimus
FDA Approved: * December 13, 2001
Pharm Company: * NOVARTIS
Category: Skin Care

Pimecrolimus is an immunomodulating agent[clarification needed] of the calcineurin inhibitor class used in the treatment of atopic dermatitis (eczema). It is available as a topical cream, once marketed by Novartis (however, Galderma has been promoting the compound in Canada since early 2007) under the trade name Elidel. Contents 1 Medical uses 2 Side effects 3 Pharmacology 4 References 5 External links Medical uses It has been proven to be effective in various inflammat... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions